Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.49M Buy
82,500
+39,400
+91% +$2.31M ﹤0.01% 3655
2026
Q1
$1.65M Sell
43,100
-5,900
-12% -$187K ﹤0.01% 6623
2025
Q4
$1.07M Buy
+49,000
New +$1.02M ﹤0.01% 7028
2024
Q3
Sell
-21,100
Closed -$835K 11916
2024
Q2
$835K Buy
+21,100
New +$683K ﹤0.01% 7013
2024
Q1
Sell
-8,300
Closed -$277K 12129
2023
Q4
$277K Buy
+8,300
New +$268K ﹤0.01% 9996
2023
Q3
Sell
-7,800
Closed -$247K 11980
2023
Q2
$247K Buy
+7,800
New +$252K ﹤0.01% 9833
2022
Q3
Sell
-6,600
Closed -$271K 13120
2022
Q2
$271K Buy
+6,600
New +$321K ﹤0.01% 9834
2021
Q3
Sell
-16,100
Closed -$966K 12707
2021
Q2
$966K Sell
16,100
-34,900
-68% -$1.75M ﹤0.01% 7874
2021
Q1
$2.4M Sell
51,000
-61,300
-55% -$2.52M ﹤0.01% 5462
2020
Q4
$4.22M Buy
112,300
+12,800
+13% +$422K ﹤0.01% 3703
2020
Q3
$3.25M Buy
99,500
+20,900
+27% +$885K ﹤0.01% 3723
2020
Q2
$3.56M Buy
78,600
+66,900
+572% +$3.42M ﹤0.01% 3511
2020
Q1
$534K Sell
11,700
-18,800
-62% -$851K ﹤0.01% 6802
2019
Q4
$1.32M Buy
+30,500
New +$1.24M ﹤0.01% 5009

Other funds holding ATEX

Jeff Yass's ATEX Position: Q2 2026 in Review

Jeff Yass reduced its Anterix (ATEX) stake by 86% in Q2 2026, selling an estimated $2.01M and leaving 5,584 shares worth $575K. The position accounts for ﹤0.01% of the portfolio, ranked #9583.

Jeff Yass first reported a position in ATEX in Q4 2016 and has held it in 29 quarters since. The position peaked at $5.44M in Q3 2020. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • Jeff Yass held 5,584 shares of Anterix worth $575K as of Q2 2026.
  • Jeff Yass sold 34,214 Anterix shares in Q2 2026, an estimated $2.01M.
  • Anterix made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #9583 holding.
  • Jeff Yass first reported a position in Anterix in Q4 2016 and has held it in 29 quarters since.
  • Jeff Yass's Anterix position peaked at $5.44M in Q3 2020.
  • 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.